Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro).
Meulenbeld HJ, van Werkhoven ED, Coenen JL, Creemers GJ, Loosveld OJ, de Jong PC, Ten Tije AJ, Fosså SD, Polee M, Gerritsen W, Dalesio O, de Wit R. Meulenbeld HJ, et al. Among authors: de wit r, de jong pc. Eur J Cancer. 2012 Nov;48(16):2993-3000. doi: 10.1016/j.ejca.2012.05.014. Epub 2012 Jun 6. Eur J Cancer. 2012. PMID: 22677260 Free article. Clinical Trial.
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
Steenbruggen TG, Bouwer NI, Smorenburg CH, Rier HN, Jager A, Beelen K, Ten Tije AJ, de Jong PC, Drooger JC, Holterhues C, Kitzen JJEM, Levin M-, Sonke GS. Steenbruggen TG, et al. Among authors: de jong pc. Breast Cancer Res Treat. 2019 Dec;178(3):597-605. doi: 10.1007/s10549-019-05427-1. Epub 2019 Sep 6. Breast Cancer Res Treat. 2019. PMID: 31493033
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
Bouwer NI, Steenbruggen TG, van Rosmalen J, Rier HN, Kitzen JJEM, van Bekkum ML, Tije AJT, de Jong PC, Drooger JC, Holterhues C, Smorenburg CH, Kofflard MJM, Boersma E, Sonke GS, Levin MD, Jager A. Bouwer NI, et al. Among authors: de jong pc. Breast Cancer Res Treat. 2021 Apr;186(3):851-862. doi: 10.1007/s10549-020-06039-w. Epub 2021 Jan 4. Breast Cancer Res Treat. 2021. PMID: 33394273 Free PMC article.
Evaluation of treatment results of squamous cell carcinoma of the buccal mucosa.
Pop LA, Eijkenboom WM, de Boer MF, de Jong PC, Knegt P, Levendag PC, Meeuwis CA, Reichgelt BA, van Putten WL. Pop LA, et al. Among authors: de boer mf, de jong pc. Int J Radiat Oncol Biol Phys. 1989 Feb;16(2):483-7. doi: 10.1016/0360-3016(89)90347-7. Int J Radiat Oncol Biol Phys. 1989. PMID: 2921152
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Opdam M, van der Noort V, Kleijn M, Glas A, Mandjes I, Kleiterp S, Hilbers FS, Kruger DT, Bins AD, de Jong PC, Schiphorst PPJBM, van Dalen T, Flameling B, Rietbroek RC, Beeker A, van den Heiligenberg SM, Bakker SD, Wymenga ANM, Oving IM, Bijlsma RM, van Diest PJ, Vermorken JB, van Tinteren H, Linn SC. Opdam M, et al. Among authors: de jong pc. Breast Cancer Res Treat. 2022 Jul;194(2):265-278. doi: 10.1007/s10549-022-06618-z. Epub 2022 May 19. Breast Cancer Res Treat. 2022. PMID: 35587322 Free PMC article. Clinical Trial.
Screening for lymph nodes in the neck with ultrasound.
Baatenburg de Jong RJ, Rongen RJ, De Jong PC, Lameris JS, Knegt P. Baatenburg de Jong RJ, et al. Among authors: de jong pc. Clin Otolaryngol Allied Sci. 1988 Feb;13(1):5-9. doi: 10.1111/j.1365-2273.1988.tb00274.x. Clin Otolaryngol Allied Sci. 1988. PMID: 3286070
71 results